Venue
Auckland
Time
9:00 am – 4:30 pm
A lack of robust market validation is one of the most common weaknesses of healthtech businesses searching for investment. This workshop is aimed at early stage healthtech companies, or healthtech companies that would like to have a fresh look at their market and how they have validated it to date. Led by Dan Hansen, director of consulting firm Apagie, and CEO of Avert Group.
Learn more and RSVP
